4
Views
14
CrossRef citations to date
0
Altmetric
Original papers

Weekly Low-Dose Adriamycin in Hormone-Resistant Metastatic Cancer of the Prostate

, &
Pages 13-16 | Received 03 Dec 1985, Published online: 15 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

H. T. Mouridsen, C. Alfthan, L. Bastholt, J. Bergh, M. Dalmark, S. Eksborg, S. Hellsten, M. Kjaer, C. Peterson, T. Skovsgård, J. B. Sørensen, C. Tropé & K. Aabo. (1990) Current Status of Epirubicin (Farmorubicin) in the Treatment of Solid Tumours. Acta Oncologica 29:3, pages 257-285.
Read now

Articles from other publishers (12)

Eleftheria Tsakalozou, Allison M. Eckman & Younsoo Bae. (2012) Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells. Biochemistry Research International 2012, pages 1-10.
Crossref
Roberto Petrioli, Anna Ida Fiaschi, Edoardo Francini, Alessandra Pascucci & Guido Francini. (2008) The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer. Cancer Treatment Reviews 34:8, pages 710-718.
Crossref
. (1999) EDITORIAL COMMENT. Journal of Urology 162:5, pages 1664-1665.
Crossref
J. E. Altwein. 1997. Uroonkologie. Uroonkologie 233 399 .
Sridhar Mani & Nicholas J. Vogelzang. (1996) IS "OFF-PROTOCOL" CHEMOTHERAPY FOR ANDROGEN-INDEPENDENT CARCINOMA OF PROSTATE WARRANTED. Hematology/Oncology Clinics of North America 10:3, pages 749-768.
Crossref
Glenn J. Bubley & Steven P. Balk. (1996) Treatment of Androgen-Independent Prostate Cancer. The Oncologist 1:1-2, pages 30-35.
Crossref
Claes Anderstr�m. (1994) Experiences with doxo/epirubicin and medroxyprogesterone acetate (MPA) in prostatic cancer. Cancer Chemotherapy and Pharmacology 35:S1, pages S97-S100.
Crossref
J. E. Altwein & M. Wirth. 1994. Uroonkologie. Uroonkologie 159 273 .
K. P. J. DELAERE, H. LELIEFELD, F. PEULEN, E. W. STAPPER, J. SMEETS & J. WILS. (1992) Phase II Study of Epirubicin in Advanced Hormone-resistant Prostatic Carcinoma. British Journal of Urology 70:6, pages 641-642.
Crossref
Christina Rangel, Haim Matzkin & Mark S. Soloway. (1992) Experience with weekly doxorubicin (adriamycin) in hormone-refractory stage D2 prostate cancer. Urology 39:6, pages 577-582.
Crossref
D. W. W. Newling. (1992) The use of adriamycin and its derivatives in the treatment of prostatic cancer. Cancer Chemotherapy and Pharmacology 30:S1, pages S90-S94.
Crossref
Stefan S. Bielack, Rudolf Erttmann, Kurt Winkler & Günther Landbeck. (1989) Doxorubicin: Effect of different schedules on toxicity and anti-tumor efficacy. European Journal of Cancer and Clinical Oncology 25:5, pages 873-882.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.